Figure 2. Relationship between receptor accessory protein 4 expression, clinical features, and molecular typing. (A) World Health Organization grade. (B) Primary, Recurrent, Secondary (PRS) type. (C) Isocitrate dehydrogenase mutation status. (D) 1p19q co-deletion status.